A Randomized Controlled Trial of Disclosing Genetic Risk Information for Alzheimer’s Disease via Telephone

[1]  S. Buys,et al.  Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Green,et al.  Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland , 2016, Journal of Genetic Counseling.

[3]  Jianxin Shi,et al.  Developing and evaluating polygenic risk prediction models for stratified disease prevention , 2016, Nature Reviews Genetics.

[4]  Deepak L. Bhatt,et al.  Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. , 2016, Annals of internal medicine.

[5]  Deepak L. Bhatt,et al.  A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[6]  R. Green,et al.  Associations between self-referral and health behavior responses to genetic risk information , 2015, Genome Medicine.

[7]  R. Green,et al.  Factors Affecting Recall of Different Types of Personal Genetic Information about Alzheimer's Disease Risk: The REVEAL Study , 2015, Public Health Genomics.

[8]  S. Buys,et al.  Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. , 2014, Journal of the National Cancer Institute.

[9]  Marisa O. Hollinshead,et al.  Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression , 2014, PloS one.

[10]  J. Garber,et al.  Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  B. Egleston,et al.  Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. , 2013, Patient education and counseling.

[12]  R. Green,et al.  Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease , 2012, Genetics in Medicine.

[13]  R. Green,et al.  Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics , 2011, Clinical genetics.

[14]  B. Egleston,et al.  Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results , 2011, Clinical genetics.

[15]  Lisa J. Martin,et al.  Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing , 2010, Familial Cancer.

[16]  R. Green,et al.  Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. , 2010, The American journal of clinical nutrition.

[17]  D. Urbauer,et al.  Assessment of clinical practices among cancer genetic counselors , 2010, Familial Cancer.

[18]  L. Zone-Smith,et al.  Comparing In-Person, Video, and Telephonic Medical Interpretation , 2010, Journal of General Internal Medicine.

[19]  Robert Cook-Deegan,et al.  Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.

[20]  E. Mills,et al.  Naturopathic Care for Anxiety: A Randomized Controlled Trial ISRCTN78958974 , 2009, PloS one.

[21]  J. Carroll.  Genetic testing: Counselors Desperately Needed. , 2009, Biotechnology healthcare.

[22]  J. Evans,et al.  Telephoned BRCA1/2 Genetic Test Results: Prevalence, Practice, and Patient Satisfaction , 2009, Journal of Genetic Counseling.

[23]  R. Green,et al.  A New Scale Measuring Psychologic Impact of Genetic Susceptibility Testing for Alzheimer Disease , 2009, Alzheimer disease and associated disorders.

[24]  C. Bolliger.  The Right Direction , 2008, Respiration.

[25]  Robert Cook-Deegan,et al.  Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience , 2008, Genetics in Medicine.

[26]  P. Ubel,et al.  Measuring Numeracy without a Math Test: Development of the Subjective Numeracy Scale , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[27]  S. Steinberg,et al.  Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling , 2007, Genetics in Medicine.

[28]  P. McEvoy,et al.  Effectiveness of cognitive behavior therapy for diagnostically heterogeneous groups: a benchmarking study. , 2007, Journal of consulting and clinical psychology.

[29]  R. Green,et al.  Recall of disclosed Apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: The REVEAL Study , 2006, Genetics in Medicine.

[30]  J. Edwards,et al.  Lost in transition: Challenges in the expanding field of adult genetics , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[31]  S. Pocock,et al.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.

[32]  R. Green,et al.  Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study , 2004, Genetics in Medicine.

[33]  K. Huelsman,et al.  Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location , 2003, Genetics in Medicine.

[34]  B. Rimer,et al.  General Performance on a Numeracy Scale among Highly Educated Samples , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[35]  K. Ormond,et al.  Recommendations for Telephone Counseling , 2000, Journal of Genetic Counseling.

[36]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[37]  J. Ramsay,et al.  Examining scale discriminability in the BDI and CES-D as a function of depressive severity. , 1995 .

[38]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[39]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[40]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[41]  Douglas G Altman,et al.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.

[42]  C. Fabian,et al.  Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial , 2005, Familial Cancer.

[43]  B. Yashar,et al.  A guide to genetic counseling , 1998 .

[44]  Christen Krogh,et al.  THE RIGHT DIRECTION , 1993 .

[45]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .